Shell Asset Management’s Outset Medical OM Stock Holding History

Shell Asset Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-272	Closed	-$44K	–	1270
2023 Q3	$44K	Sell	272 -4	-1%	-$944	﹤0.01%	1204
2023 Q2	$91K	Sell	276 -2	-0.7%	-$610	﹤0.01%	1140
2023 Q1	$77K	Sell	278 -1	-0.4%	-$367	﹤0.01%	1151
2022 Q4	$108K	Sell	279 -22	-7%	-$6.2K	﹤0.01%	1135
2022 Q3	$72K	Sell	301 -40	-12%	-$10.7K	﹤0.01%	1292
2022 Q2	$76K	Buy	341 +1	+0.3%	+$430	﹤0.01%	1325
2022 Q1	$232K	Sell	340 -51	-13%	-$30.7K	0.01%	1135
2021 Q4	$270K	Buy	391 +2	+0.5%	+$1.48K	0.01%	1131
2021 Q3	$288K	Sell	389 -17	-4%	-$11.6K	0.01%	1094
2021 Q2	$304K	Buy	+406	New	+$310K	0.01%	1115

Other funds holding OM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Shell Asset Management's OM Position: Q4 2023 in Review

Shell Asset Management sold out of Outset Medical (OM) in Q4 2023, closing a stake of 272 shares — an estimated $44K sold.

Shell Asset Management first reported a position in OM in Q2 2021 and held it in 10 quarters. The position peaked at $304K in Q2 2021. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

Shell Asset Management reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
Shell Asset Management sold 272 Outset Medical shares in Q4 2023, an estimated $44K.
Shell Asset Management first reported a position in Outset Medical in Q2 2021 and held it in 10 quarters.
Shell Asset Management's Outset Medical position peaked at $304K in Q2 2021.
140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Shell Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.